GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
7.48
-0.58 (-7.20%)
At close: May 17, 2024, 4:00 PM
7.36
-0.12 (-1.60%)
After-hours: May 17, 2024, 7:36 PM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 9.11, with a low estimate of 5.50 and a high estimate of 16. The average target predicts an increase of 21.79% from the current stock price of 7.48.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GDRX stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 4 |
| Buy | 2 | 2 | 2 | 5 | 6 | 6 |
| Hold | 10 | 10 | 10 | 9 | 8 | 8 |
| Sell | 0 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 17 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Hold → Buy Upgrades $10 | Hold → Buy | Upgrades | $10 | +33.69% | May 16, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +113.90% | May 16, 2024 |
| Keybanc | Keybanc | Hold → Buy Upgrades $9 | Hold → Buy | Upgrades | $9 | +20.32% | Apr 10, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $10 | Hold → Buy | Upgrades | $10 | +33.69% | Mar 25, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $8 | Hold | Reiterates | $8 | +6.95% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
816.79M
from 750.27M
Increased by 8.87%
Revenue Next Year
875.95M
from 816.79M
Increased by 7.24%
EPS This Year
0.37
from -0.02
EPS Next Year
0.46
from 0.37
Increased by 22.63%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 849.7M | 967.6M | 1.1B | 1.3B | 1.4B |
| Avg | 816.8M | 876.0M | 949.9M | 1.1B | 1.2B |
| Low | 781.1M | 817.3M | 865.6M | 929.4M | 978.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.3% | 18.5% | 28.1% | 32.4% | 31.5% |
| Avg | 8.9% | 7.2% | 8.4% | 11.6% | 11.9% |
| Low | 4.1% | 0.1% | -1.2% | -2.2% | -7.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.53 | 0.76 | 0.79 | 1.06 | 1.41 |
| Avg | 0.37 | 0.46 | 0.55 | 0.75 | 1.37 |
| Low | 0.27 | 0.33 | 0.42 | 0.46 | 1.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 101.8% | 71.4% | 92.5% | 86.4% |
| Avg | - | 22.6% | 19.9% | 37.0% | 81.1% |
| Low | - | -11.1% | -8.7% | -16.4% | 74.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.